5Am Opportunities I (Gp), LLC
CIK 0001790778 Name as filed on the most recent filing
Filed as 5Am Opportunities I (Gp), LLC (41)
111 transaction lines · from 41 filings · filed 2019-10-09 to 2026-08-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Entrada Therapeutics, Inc. 6 filings
- ISSUER Enliven Therapeutics, Inc. 4 filings
- ISSUER Pear Therapeutics, Inc. 6 filings
- ISSUER scPharmaceuticals Inc. 3 filings
- ISSUER CinCor Pharma, Inc. 2 filings
- ISSUER Rallybio Corp 4 filings
- ISSUER Vor Biopharma Inc. 2 filings
- ISSUER Cabaletta Bio, Inc. 5 filings
- ISSUER Impel Neuropharma Inc 1 filings
- ISSUER Akouos, Inc. 2 filings
- ISSUER Ideaya Biosciences, Inc. 1 filings
- ISSUER Aprea Therapeutics, Inc. 5 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-07 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 52,317 disposed | 6.85 | 358,371.45 | Form 4, filing 0001231919-26-000854 | |
| 2026-08-06 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 10,494 disposed | 7.00 | 73,458.00 | Form 4, filing 0001231919-26-000854 | |
| 2026-07-31 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 1,718 disposed | 6.85 | 11,768.30 | Form 4, filing 0001231919-26-000822 | |
| 2026-07-30 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 114,756 disposed | 6.93 | 795,259.08 | Form 4, filing 0001231919-26-000822 | |
| 2025-11-14 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 200,000 disposed | 8.80 | 1,760,000.00 | Form 4, filing 0001231919-25-000522 | |
| 2025-07-09 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 20,065 disposed | 7.50 | 150,527.63 | Form 4, filing 0001415889-25-019677 | |
| 2025-07-09 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 6,935 disposed | 7.50 | 52,026.37 | Form 4, filing 0001415889-25-019677 | |
| 2025-07-01 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 18,578 disposed | 7.12 | 132,323.66 | Form 4, filing 0001415889-25-018822 | |
| 2025-07-01 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 6,422 disposed | 7.12 | 45,741.34 | Form 4, filing 0001415889-25-018822 | |
| 2025-06-30 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 18,578 disposed | 6.81 | 126,566.34 | Form 4, filing 0001415889-25-018822 | |
| 2025-06-30 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 6,422 disposed | 6.81 | 43,751.16 | Form 4, filing 0001415889-25-018822 | |
| 2025-06-27 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 55,735 disposed | 6.91 | 385,128.85 | Form 4, filing 0001415889-25-018822 | |
| 2025-06-27 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 19,265 disposed | 6.91 | 133,121.15 | Form 4, filing 0001415889-25-018822 | |
| 2024-02-14 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 688,358 disposed | 14.90 | 10,256,534.20 | Form 4, filing 0001415889-24-004111 | |
| 2024-02-14 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 136,642 disposed | 14.90 | 2,035,965.80 | Form 4, filing 0001415889-24-004111 | |
| 2024-01-31 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 417,187 disposed | 15.00 | 6,257,805.00 | Form 4, filing 0001415889-24-002295 | |
| 2024-01-31 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 82,813 disposed | 15.00 | 1,242,195.00 | Form 4, filing 0001415889-24-002295 | |
| 2023-09-26 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 164,789 disposed | 15.00 | 2,471,835.00 | Form 4, filing 0001209191-23-050731 | |
| 2023-09-26 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 32,711 disposed | 15.00 | 490,665.00 | Form 4, filing 0001209191-23-050731 | |
| 2023-08-24 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 367,124 disposed | 16.00 | 5,873,984.00 | Form 4, filing 0001209191-23-047514 | |
| 2023-08-24 |
Enliven Therapeutics, Inc. ELVN |
S, Open-market sale | 72,876 disposed | 16.00 | 1,166,016.00 | Form 4, filing 0001209191-23-047514 | |
| 2023-04-10 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 12,836,489 disposed | 0.12 | 1,540,378.68 | Form 4, filing 0001209191-23-024105 | |
| 2023-04-10 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 3,172,769 disposed | 0.12 | 380,732.28 | Form 4, filing 0001209191-23-024105 | |
| 2023-04-10 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 534,855 disposed | 0.12 | 64,182.60 | Form 4, filing 0001209191-23-024105 | |
| 2022-11-15 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 61,222 disposed | 2.52 | 154,279.44 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-15 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 2,551 disposed | 2.52 | 6,428.52 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-14 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 11,643 disposed | 2.79 | 32,483.97 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-14 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 485 disposed | 2.79 | 1,353.15 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-11 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 28,205 disposed | 3.19 | 89,973.95 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-11 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 1,175 disposed | 3.19 | 3,748.25 | Form 4, filing 0001209191-22-057195 | |
| 2022-11-02 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 10,155 disposed | 2.72 | 27,621.60 | Form 4, filing 0001209191-22-055425 | |
| 2022-11-02 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 423 disposed | 2.72 | 1,150.56 | Form 4, filing 0001209191-22-055425 | |
| 2022-11-01 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 1,408 disposed | 2.80 | 3,942.40 | Form 4, filing 0001209191-22-055425 | |
| 2022-11-01 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 59 disposed | 2.80 | 165.20 | Form 4, filing 0001209191-22-055425 | |
| 2022-10-31 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 40,477 disposed | 2.78 | 112,526.06 | Form 4, filing 0001209191-22-055425 | |
| 2022-10-31 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 1,687 disposed | 2.78 | 4,689.86 | Form 4, filing 0001209191-22-055425 | |
| 2022-10-10 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 456,413 disposed | 4.09 | 1,866,729.17 | Form 4, filing 0001209191-22-053401 | |
| 2022-10-10 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 87,036 disposed | 4.09 | 355,977.24 | Form 4, filing 0001209191-22-053401 | |
| 2022-10-10 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 19,017 disposed | 4.09 | 77,779.53 | Form 4, filing 0001209191-22-053401 | |
| 2022-10-06 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 30,457 disposed | 5.02 | 152,894.14 | Form 4, filing 0001209191-22-053401 | |
| 2022-10-06 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 5,808 disposed | 5.02 | 29,156.16 | Form 4, filing 0001209191-22-053401 | |
| 2022-10-06 |
scPharmaceuticals Inc. SCPH |
S, Open-market sale | 1,269 disposed | 5.02 | 6,370.38 | Form 4, filing 0001209191-22-053401 | |
| 2022-09-16 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 337 disposed | 1.75 | 589.75 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-16 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 14 disposed | 1.75 | 24.50 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-15 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 261,840 disposed | 1.81 | 473,930.40 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-15 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 10,910 disposed | 1.81 | 19,747.10 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-14 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 273,664 disposed | 1.94 | 530,908.16 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-14 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 11,403 disposed | 1.94 | 22,121.82 | Form 4, filing 0001209191-22-050387 | |
| 2022-09-08 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 292,149 disposed | 1.81 | 528,789.69 | Form 4, filing 0001209191-22-049237 | |
| 2022-09-08 |
Pear Therapeutics, Inc. PEAR |
S, Open-market sale | 12,173 disposed | 1.81 | 22,033.13 | Form 4, filing 0001209191-22-049237 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. 5AM Opportunities I (GP), LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001790778
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6